AKT1 and glioma: In short, our research found that the high level of miR-155 in gliomas can promote the proliferation, invasion and migration of U87-MG glioma cells, inhibit their senescence and apoptosis, and activate the PI3K/AKT signal pathway, thus aggravating the occurrence and development of gliomas.